Active immunization with pC protein ofBorrelia burgdorferi protects gerbils againstB. burgdorferi infection

V. Preac‐Mursic, Bettina Wilske, Sigrid Jauris, +7

Infection

Veterinary VaccinePc ProteinPathogenesisImmunologyTick-borne Disease +5

Acylated simian virus 40 large T-antigen: a new subclass associated with a detergent-resistant lamina of the plasma membrane.

U. Klockmann, Wolfgang Deppert

The EMBO Journal

Virus StructureDetergent-resistant LaminaPlasma MembranePathogenesisViral Pathogenesis +7

Monoclonal antibodies directed against tick-borne encephalitis virus with neutralizing activity in vivo.

Matthias Niedrig, U. Klockmann, W Lang, +4

PubMed

Viral DiagnosticsViral PathogenesisImmunologyNeutralizing ActivityViral Structural Protein +15

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

I. Harabacz, H.L. Bock, Ch. Jüngst, +3

Vaccine

VaccinationVaccine DevelopmentMedicineImmunologyImmunization Regimens +3

Comparison of six different commercial IgG-ELISA kits for the detection of TBEV-antibodies

Matthias Niedrig, D. Vaisviliene, Anette Teichmann, +2

Journal of Clinical Virology

VaccinationImmunodeficienciesImmunologySerologic TestingTuberculosis +5

Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine

U. Klockmann, K. Křivanec, John Stephenson, +1

Vaccine

VaccinationVaccine SafetyEuropean IsolatesVaccine DevelopmentVaccine Target +6

Acylation: A new post‐translational modification specific for plasma membrane‐associated simian virus 40 large T‐antigen

U. Klockmann, Wolfgang Deppert

FEBS Letters

Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine

U. Klockmann, H.L. Bock, V. Franke, +3

Journal of Biological Standardization

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentImmunology +5

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

U. Klockmann, H.L. Bock, H. Kwasny, +4

Vaccine

VaccinationManifest DiseaseTick-borne Encephalitis VirusHumoral ResponseImmunology +8

Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure

Thomas Nowak, Jens‐Peter Gregersen, U. Klockmann, +2

Journal of Medical Virology

VaccinationDiagnostic VirologyVirus SafetyHepatitis CViral Hepatitis +10